Goldman, Blackstone, and Apollo bankroll $976m loan for Asia pharma buyout ' Private Equity Insights
The loan underpins a A$2.37bn transaction and underscores the growing importance of private credit in financing large buyouts in Australia. The financing is covenant-lite, carries leverage of around 6.5x earnings, and pays a margin of roughly 475 basis points over the Bank Bill Swap Bid Rate, according to people familiar with the matter. The transaction highlights how private equity firms are increasingly turning to private credit as traditional bank lending remains constrained. However, the deal also comes as Australia's regulator has stepped up scrutiny of the asset class, citing concerns over valuations, fee transparency, and conflicts of interest. Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today.
learn more
